Exploring breakthroughs in hemoglobinopathies and bleeding disorders
Focus areas: Thalassemia, Sickle Cell Disease, Hemophilia, Acquired Hemophilia, and Von Willebrand’s Disease.
When
Saturday, October 31, 2026 · 5:00 p.m.
+04 (GMT +4:00)
Agenda
5:00 - 5:05 PM - Introduction and Program Overview - Dr. Asma Sultan Al Olama & Prof. Robert Siegel
5:05 - 5:25 PM - Industry Symposium by Amgen: Why First TPO-RA Matters: Exploring Pathway to Remission - Dr Hassan Al Yaseen
5:25 - 5:45 PM - From Evidence to Implementation: integrating Blunatumomab into Frontline B-ALL Care - Dr Ammar Al Habib
6:55 - 7:05 PM - Hematologic Complications of Pregnancy - Prof. Robert Siegel
7:05 PM - 7:35 PM - Hematopathology Myeloid and Lymphoid- Prof Robert Hassarjian
7:35 - 7:50 PM - Bone Marrow Transplantation - Dr. Matt Ulrickson
7:50 - 8:05 PM - Amyloidosis and Waldenstrom's - Dr. Morie Gertz
Presenters
Robert Siegel
Speaker
Professor of Medicine
George Washington University School of Medicine & Health Sciences
United States
Ayalew Tefferi
Speaker
Professor of Medicine
Department of Hematology
Mayo Clinic Transplant Center
United States
Morie Gertz
Speaker
Consultant - Division of Hematology
Department of Internal Medicine
Mayo Clinic, Rochester, Minnesota
United States
Matthew Ulrickson
Speaker
Chief, Section of Hematology
Banner MD Anderson Cancer Center
United States
Robert Hasserjian
Speaker
Program Director, Mass General Brigham Hematopathology Fellowship, Massachusetts General Hospital Site Director
Professor of Pathology, Harvard Medical School
You’re registered
Check your email for a confirmation and link to attend the live session.
medULive uses cookies to ensure the security of your session, support CME attendance verification, and improve your experience. By clicking "Accept", you consent to our use of cookies in accordance with our Cookie Policy and the UAE Personal Data Protection Law (PDPL). You may decline non-essential cookies — this will not affect your CME credit eligibility.